A review of the safety and efficacy of current COVID-19 vaccines

Z Huang, Y Su, T Zhang, N Xia - Frontiers of Medicine, 2022 - Springer
Vaccination is the most effective and feasible way to contain the Coronavirus disease 2019
(COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an …

Recent advances in vaccine and immunotherapy for COVID-19

AA Rabaan, SH Al-Ahmed, R Sah… - Human vaccines & …, 2020 - Taylor & Francis
The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and
hundreds of thousands of deaths. Beyond there being no available antiviral therapy …

The safety profile of COVID-19 vaccinations in the United States

A Singh, R Khillan, Y Mishra, S Khurana - American journal of infection …, 2022 - Elsevier
Abstract Background/Aim Pfizer-BioNTech, Moderna, and Johnson & Johnson's Janssen are
the 3 COVID-19 vaccines authorized for emergency use in the United States. This study …

COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations

Q He, Q Mao, J Zhang, L Bian, F Gao, J Wang… - Frontiers in …, 2021 - frontiersin.org
The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …

Adverse events following COVID-19 vaccination: A systematic review and meta-analysis

H Kouhpayeh, H Ansari - International Immunopharmacology, 2022 - Elsevier
Background High speed of COVID-19 vaccination has raised some concerns about the
safety of the new vaccines. It is of a great importance to perform a review of the safety and …

COVID-19 vaccines: breaking record times to first-in-human trials

YC Kim, B Dema, A Reyes-Sandoval - npj Vaccines, 2020 - nature.com
COVID-19 vaccines: breaking record times to first-in-human trials | npj Vaccines Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …

Review of current vaccine development strategies to prevent coronavirus disease 2019 (COVID-19)

BM Bennet, J Wolf, R Laureano… - Toxicologic …, 2020 - journals.sagepub.com
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak that started in
Wuhan, China, in 2019 resulted in a pandemic not seen for a century, and there is an urgent …

Postlicensure evaluation of COVID-19 vaccines

MM Patel, ML Jackson, J Ferdinands - JAMA, 2020 - jamanetwork.com
After rigorous clinical trialsof vaccines for severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have established safety and efficacy, and after vaccines are deployed …

Vaccines for COVID-19

JS Tregoning, ES Brown… - Clinical & …, 2020 - academic.oup.com
Since the emergence of COVID-19, caused by the SARS-CoV-2 virus at the end of 2019,
there has been an explosion of vaccine development. By 24 September 2020, a staggering …

Avoiding pitfalls in the pursuit of a COVID-19 vaccine

L Peeples - Proceedings of the national academy of …, 2020 - National Acad Sciences
The teams of researchers scrambling to develop a coronavirus disease 2019 (COVID-19)
vaccine clearly face some big challenges, both scientific and logistical. One of the most …